Peter Emtage
InvestorVenture Partner at Versant Ventures
San Francisco Bay Area
Writes $100K β $5M checks Β· typically $1.5M
FoundedSanta Ana Bio
About
Peter Emtage joined Versant Ventures as an Entrepreneur-in-Residence in October 2020 and became a Venture Partner in April 2021. He previously led cell therapy research at Kite Pharma (a Gilead company) and held senior scientific roles at Cell Design Labs and MedImmune, with over 20 years of drug development experience in oncology, autoimmunity, infectious diseases and inflammation.
Experience
- Santa Ana Bio, IncChief Executive Officercurrent2021 β present
- Versant VenturesVenture Partnercurrent2020 β present
- Kite PharmaGlobal Head of Cell Therapy Research2018 β 2020
- Cell Design LabsChief Scientific Officer2016 β 2018San Francisco, California
Skills & more
IND1Clinical Development99Biochemistry46Infectious Diseases23Cell Culture19GLP8Drug Discovery99GMP6Clinical Research10FDA13Antibodies13Vaccines6
+12 more
PharmacologyBiologicsBiotherapeuticsAssay DevelopmentInflammationAutoimmunityOncologyBiomarker DiscoveryBiotechnologyBiopharmaceuticalsCancerCellLanguages English
From Peter's professional profile.
Shared employers
Also worked at Santa Ana Bio, Inc4
Also worked at Kite Pharma6
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures















